ADIPOQ and hepatocellular carcinoma: Moreover, immunopositivity for adiponectin was correlated with smaller tumor size and better survival of HCC patients [75], which contrasts the findings of another study of similar design that showed the immunopositivity for adiponectin in HCC tissue was associated with a poor survival rate in HCC patients [76].